Etoposide/Selected P-glycoprotein (P-gp) Inhibitors Interactions
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Moderate. These medicines may cause some risk when taken together. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
When these two medicines are taken together, your body may not process etoposide properly.
What might happen:
An increase in the toxic effects of etoposide may occur.
What you should do about this interaction:
Your healthcare professionals (e.g. doctor or pharmacist) may already be aware of the interaction and may be monitoring you for it. If your doctor prescribes these medicines together, you may need to have your blood monitored more frequently.If you develop a persistent sore throat or fever; black, tarry stools; or blood in urine or stools, contact your doctor as soon as possible. The dose of your medicines may need adjusting. Do not start, stop, or change the dosage of any medicine before checking with them first.
- 1.Lum BL, Kaubisch S, Yahanda AM, Adler KM, Jew L, Ehsan MN, Brophy NA, Halsey J, Gosland MP, Sikic BI. Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol 1992 Oct;10(10):1635-42.
- 2.Yang J, Bogni A, Schuetz EG, Ratain M, Dolan ME, McLeod H, Gong L, Thorn C, Relling MV, Klein TE, Altman RB. Etoposide pathway. Pharmacogenet Genomics 2009 Jul;19(7):552-3.
- 3.Lagas JS, Fan L, Wagenaar E, Vlaming ML, van Tellingen O, Beijnen JH, Schinkel AH. P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 determine the pharmacokinetics of etoposide. Clin Cancer Res 2010 Jan 01;16(1):130-40.
- 4.This information is based on or an extract from the UW Metabolism and Transport Drug Interaction Database (DIDB) Platform, Copyright University of Washington 1999-2019..